Recombinant CD27 (Varlilumab Biosimilar) antibody

Catalog No. ABIN6964431

The Human Monoclonal anti-CD27 (Varlilumab Biosimilar) antibody has been validated for ELISA and FACS. It is suitable to detect CD27 (Varlilumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD27 (Varlilumab Biosimilar) antibody (ABIN6964431)

Target: CD27 (Varlilumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD27 (Varlilumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-CD27 (Varlilumab Biosimilar) Antibody

Purpose: Anti-CD27 (varlilumab biosimilar) mAb

Characteristics: 1F5, CDX-1127

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CD27 (Varlilumab Biosimilar)

Target: CD27 (Varlilumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: CD27, TNFRSF7, S152, T14, Tp55

UniProt: P26842